Literature DB >> 30901133

Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis.

Wai Gin Lee1, Cameron I Wells1, John L McCall2, Rinki Murphy3, Lindsay D Plank1.   

Abstract

An association between diabetes mellitus (DM) and liver cirrhosis is well-known, but estimates of the prevalence of DM in patients with liver cirrhosis vary widely. A systematic review was undertaken to determine the prevalence of DM in adult patients with liver cirrhosis. The Medline, EMBASE, and Cochrane Library databases were searched for peer-reviewed studies published in English (1979-2017) that investigated the prevalence of diabetes in adult patients with cirrhosis. Pooled estimates of prevalence of DM were determined for all eligible patients and according to aetiology and severity of liver disease. Fifty-eight studies satisfied criteria for inclusion, with 9705 patients included in the pooled prevalence analysis. The overall prevalence of DM was 31%. The prevalence of DM was highest in patients with nonalcoholic fatty liver disease (56%), cryptogenic (51%), hepatitis C (32%), or alcoholic (27%) cirrhosis. For assessing prevalence of DM as a function of severity of liver disease, evaluable data were available only for hepatitis C and hepatitis B cirrhosis. DM may be more prevalent in cirrhosis than previously thought. This has implications for prognosis and treatment in these patients.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetes; disease aetiology; disease severity; liver disease; prevalence

Mesh:

Year:  2019        PMID: 30901133     DOI: 10.1002/dmrr.3157

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  11 in total

Review 1.  Hepatogenous Diabetes: A Primer.

Authors:  Preetam Nath; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-05-01

Review 2.  An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist.

Authors:  Pankaj Puri; Narendra Kotwal
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

3.  Hepatogenous Diabetes - A Report from Central India.

Authors:  Praveen Vasepalli; Mohd T Noor; Bhagwan S Thakur
Journal:  J Clin Exp Hepatol       Date:  2021-08-25

4.  Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.

Authors:  Xiu Sun; Xin Chi; Yingying Zhao; Shunai Liu; Huichun Xing
Journal:  J Diabetes Res       Date:  2022-05-13       Impact factor: 4.061

Review 5.  Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.

Authors:  Maja Cigrovski Berkovic; Lucija Virovic-Jukic; Ines Bilic-Curcic; Anna Mrzljak
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

6.  Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.

Authors:  Romina Lomonaco; Eddison Godinez Leiva; Fernando Bril; Sulav Shrestha; Lydia Mansour; Jeff Budd; Jessica Portillo Romero; Siegfried Schmidt; Ku-Lang Chang; George Samraj; John Malaty; Katherine Huber; Pierre Bedossa; Srilaxmi Kalavalapalli; Jonathan Marte; Diana Barb; Danielle Poulton; Nada Fanous; Kenneth Cusi
Journal:  Diabetes Care       Date:  2020-12-21       Impact factor: 19.112

7.  A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III.

Authors:  Ghada Hijazi; Anna Paschall; Sarah P Young; Brian Smith; Laura E Case; Tracy Boggs; Sathya Amarasekara; Stephanie L Austin; Surekha Pendyal; Areeg El-Gharbawy; Kristen L Deak; Andrew J Muir; Priya S Kishnani
Journal:  Mol Genet Metab Rep       Date:  2021-11-11

8.  Morbimortality Associated with Liver Cirrhosis in Peru: An Ecological Analysis for the Period of 2004-2016.

Authors:  Daniela Rojas-Acuña; Nilo Polo-Samillan; Angie Z Vasquez-Chavesta; Crist Escalante-Arias; Cristhian J Rios-Perez; Carlos J Toro-Huamanchumo
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

9.  Type 2 Diabetes, PNPLA3 rs738409 Polymorphism, and the Risk of Liver Cirrhosis: Analysis of Taiwan Biobank.

Authors:  Kuan-Chun Hsueh; Oswald Ndi Nfor; Shu-Yi Hsu; Shun-Fa Yang; Yung-Po Liaw
Journal:  Front Genet       Date:  2022-03-07       Impact factor: 4.599

10.  High Albumin Level Is Associated With Regression of Glucose Metabolism Disorders Upon Resolution of Acute Liver Inflammation in Hepatitis B-Related Cirrhosis.

Authors:  Caiyun Tian; Yanping Zhu; Yujuan Liu; Han Hu; Qijiao Cheng; Fangwan Yang; Lingqi Pei; Yihong Zhou; Ying Li; Shide Lin
Journal:  Front Cell Infect Microbiol       Date:  2022-02-22       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.